Description
Sabatolimab Biosimilar - Anti-HAVCR2 mAb - Research Grade
Target
HAVCR2
Target Alias Name
Sabatolimab/ANTI-TIM3 CHECKPOINT INHIBITOR MBG453/ IMMUNOGLOBULIN G4 (226-PROLINE/DE-C-TERMINAL-LYSINE)/ ANTI-(HUMAN HEPATITIS VIRUS A CELLULAR RECEPTOR 2) (HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS260714 .GAMMA.4-CHAIN)/ DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS260714 .KAPPA.-CHAIN/ DIMER/ IMMUNOGLOBULIN G4-KAPPA/ ANTI-(HOMO SAPIENS HAVCR2 (HEPATITIS A VIRUS CELLULAR RECEPTOR 2/ T-CELL IMMUNOGLOBULIN MUCIN FAMILY MEMBER 3/ TIM-3/ TIM3/ TIMD3/ CD366))/ HUMANIZED MONOCLONAL ANTIBODY/ MBG-453//HAVCR2/anti-HAVCR2
Isotype/Mimetic
IgG4/Kappa
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Unknown
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Unknown discovery source/method, In vitro recombinant expression